Scottish researchers say that many women are risking their lives by skipping doses of the breast cancer drug tamoxifen. The study found that as many as 50 percent of women did not finish the full five-year course of the drug, and one in five regularly skipped a dose. But researchers say that women who missed a dose approximately once a week were 10 percent more likely to die than women who took the medicine every day. Younger women were more likely to stop taking the drug before the end of the...
Read moreI recently read that fainting dieters are one of the top reasons that New York subway trains run late! And according to the Metropolitan... Read more »
Winter is officially here. The days are shorter. The sun’s rays are not as strong. So can we skip using our sunscreen? Dr. Lawrence... Read more »
If your period is late, you might immediately think you are pregnant. But while pregnancy is certainly a common reason, this isn’t always... Read more »
We keep putting one foot in front of the other, day after day. We do what is in front of us, to the best of our ability. And time goes by.... Read more »
It’s a common question that often is asked on HealthCentral’s menopause site - What’s a normal period when you’re going through... Read more »
The YAZ pill should be available in the U.S. as a contraceptive by April 2006, says the manufacturer. But its use as an alternative to Paxil, Zoloft,... Read more »
October 1: Its not too late to register for a Race for the Cure event near you. Women all over the country have been walking, running,... Read more »
A study published in Diabetes Care has found that 57 percent of diabetics have intentionally skipped a dose of insulin. One in five patients even... Read more »
A reader who is trying to maintain a healthy diet wants to know if eating whole eggs is a good choice. Dr. Mehmet Oz and Dr. Michael Roizen respond... Read more »
Financial concerns keep many cancer survivors from receiving medical treatments, a new study has found. Two million survivors skipped a medical... Read more »